Pyxis Oncology, Inc. (NASDAQ:PYXS) currently has 72 active institutional owners and shareholders as of today (September 2025), that have filed 13F forms with the Securities Exchange Commission (SEC).
| Owner Name | Date | Shares Held | Change (QoQ) | Change (%) | Value (USD) |
|---|---|---|---|---|---|
| PFIZER INC | 30 Sep, 2025 | 7,032,770 | 0 | 0.00% | $15,612,750.00 |
| Laurion Capital Management LP | 30 Sep, 2025 | 3,625,974 | 0 | 0.00% | $8,049,662.00 |
| TANG CAPITAL MANAGEMENT LLC | 30 Sep, 2025 | 2,500,000 | 0 | 0.00% | $5,550,000.00 |
| VANGUARD GROUP INC | 30 Sep, 2025 | 2,163,962 | 14,566 | 0.68% | $4,803,996.00 |
| PERCEPTIVE ADVISORS LLC | 30 Sep, 2025 | 1,178,307 | 989,845 | 525.22% | $2,615,842.00 |
| Palo Alto Investors LP | 30 Sep, 2025 | 1,037,421 | 0 | 0.00% | $2,303,075.00 |
| MILLENNIUM MANAGEMENT LLC | 30 Sep, 2025 | 815,331 | -2,724,529 | -76.97% | $1,810,035.00 |
| STEMPOINT CAPITAL LP | 30 Sep, 2025 | 689,538 | -160,672 | -18.90% | $1,530,774.00 |
| BlackRock, Inc. | 30 Sep, 2025 | 683,702 | -243,103 | -26.23% | $1,517,818.00 |
| BANK OF AMERICA CORP /DE/ | 30 Sep, 2025 | 615,922 | 593,853 | 2,690.89% | $1,367,347.00 |
| RENAISSANCE TECHNOLOGIES LLC | 30 Sep, 2025 | 576,336 | 158,514 | 37.94% | $1,279,466.00 |
| GEODE CAPITAL MANAGEMENT, LLC | 30 Sep, 2025 | 544,508 | 33,545 | 6.57% | $1,209,225.00 |
| 683 Capital Management, LLC | 30 Sep, 2025 | 525,000 | -20,000 | -3.67% | $1,165,500.00 |
| Longaeva Partners L.P. | 30 Sep, 2025 | 503,214 | 503,214 | 0.00% | $1,117,135.00 |
| DRIEHAUS CAPITAL MANAGEMENT LLC | 30 Sep, 2025 | 418,632 | 418,632 | 0.00% | $929,363.00 |
| UBS Group AG | 30 Sep, 2025 | 373,727 | -22,369 | -5.65% | $829,674.00 |
| CITADEL ADVISORS LLC | 30 Sep, 2025 | 337,359 | 61,408 | 22.25% | $748,937.00 |
| Decheng Capital LLC | 30 Sep, 2025 | 326,810 | 0 | 0.00% | $725,518.00 |
| JANE STREET GROUP, LLC | 30 Sep, 2025 | 303,700 | -32,384 | -9.64% | $674,214.00 |
| SCHULHOFF & CO INC | 30 Sep, 2025 | 275,000 | 0 | 0.00% | $610,500.00 |